Ayala Pharmaceuticals Inc (ADXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 10-2022 | 10-2021 | 10-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -48,072 | -38,013 | -14,359 | -17,862 | -26,469 |
| Depreciation Amortization | 369 | 162 | 473 | 1,084 | 2,622 |
| Accounts receivable | 234 | -234 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -724 | -472 | N/A | N/A | N/A |
| Other Working Capital | 1,104 | 1,097 | 313 | 420 | -1,847 |
| Other Operating Activity | 17,604 | 2,950 | -1,711 | 919 | 3,754 |
| Operating Cash Flow | $-29,485 | $-34,510 | $-15,284 | $-15,439 | $-21,940 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 4,000 | N/A | 35 | 449 | N/A |
| Net Acquisitions | 1,909 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | -201 | -460 | -748 |
| Other Investing Activity | 37 | -2 | -201 | -460 | -748 |
| Investing Cash Flow | $5,946 | $-2 | $-166 | $-11 | $-748 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 6,000 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 20,001 | -103 | N/A | 31,886 | 15,503 |
| Other Financing Activity | 0 | 0 | -956 | 0 | 0 |
| Financing Cash Flow | $26,001 | $-103 | $-956 | $31,886 | $15,503 |
| Exchange Rate Effect | 26 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 2,724 | 37,339 | 41,614 | 25,178 | 32,363 |
| End Cash Position | 5,212 | 2,724 | 25,208 | 41,614 | 25,178 |
| Net Cash Flow | $2,488 | $-34,615 | $-16,406 | $16,436 | $-7,185 |
| Free Cash Flow | |||||
| Operating Cash Flow | -29,485 | -34,510 | -15,284 | -15,439 | -21,940 |
| Free Cash Flow | -29,485 | -34,510 | -15,284 | -15,439 | -21,940 |